SEPHS1

SEPHS1 is a selenophosphate synthetase paralog that has lost selenophosphate synthesis activity but retains ATPase activity, functioning primarily as a guardian of cellular redox homeostasis essential for embryonic development and cell differentiation (PMID:36202216, PMID:34769078). SEPHS1 physically associates with SEPHS2, SEPSECS, and SECp43 within the selenocysteine biosynthesis complex, though its own catalytic role is independent of selenophosphate production (PMID:28414460, PMID:18156471). Loss of SEPHS1 causes superoxide and lipid peroxide accumulation through induction of xanthine oxidase and NADPH oxidase coupled with decreased SOD activity, progressively dysregulating retinoic acid, Wnt, TGF-β/SMAD, and Hippo-Yap/Taz signaling pathways, ultimately triggering DNA damage and apoptosis (PMID:34769076, PMID:34769078, PMID:38105759, PMID:33622411). Heterozygous missense variants in SEPHS1 cause a neurodevelopmental disorder characterized by developmental delay, hypotonia, and dysmorphic features (PMID:38531365).

1. 2003 High

   The first functional link between SEPHS1/SPS1 and redox biology was established when Drosophila selD null mutants were shown to accumulate ROS and activate a p53–caspase apoptotic cascade, revealing that SPS1 loss is cell-lethal through oxidative stress rather than simply through selenoprotein depletion.

   Evidence Genetic null mutation in Drosophila imaginal discs with epistasis analysis of Dmp53, reaper, DRONC, DRICE, and rescue by DIAP1

   PMID:14576353

   Open questions at the time

   • Mechanism by which SPS1 loss elevates ROS was unknown
   • Whether this apoptotic pathway operates in mammals was untested
   • Whether SPS1 function is separable from selenoprotein biosynthesis was unclear
2. 2004 Medium

   Establishing that SEPHS1 and SEPHS2 differ in selenium substrate preference resolved a long-standing ambiguity about paralog redundancy: SEPHS1 preferentially uses L-selenocysteine (salvage pathway) rather than selenite, suggesting distinct metabolic roles for the two paralogs.

   Evidence In vivo complementation of E. coli selD mutant with different selenium sources; formate dehydrogenase H activity readout

   PMID:15534230

   Open questions at the time

   • Whether SEPHS1 synthesizes selenophosphate at all under physiological conditions was debated
   • The biological significance of substrate specificity in mammalian cells was not addressed
   • Complementation was weak, leaving open whether it reflects a secondary activity
3. 2008 Medium

   Comparative genomics across arthropods demonstrated that SPS1 orthologs persist in species that completely lack selenoproteins and Sec incorporation machinery, definitively establishing that SPS1 functions in a pathway independent of selenoprotein biosynthesis.

   Evidence Phylogenomic analysis of selenoproteomes across insects including Tribolium castaneum and Bombyx mori

   PMID:18156471

   Open questions at the time

   • The selenoprotein-independent function of SPS1 was not identified
   • Whether the selenoprotein-independent role is conserved in vertebrates was unknown
4. 2017 High

   Despite functioning independently of selenophosphate synthesis, SEPHS1 was shown to physically associate with SEPHS2, SEPSECS, and SECp43 within the selenocysteine biosynthesis complex, establishing it as a structural component that may regulate complex assembly or activity.

   Evidence BRET assay and co-immunoprecipitation in mammalian cells; SAXS of SECp43; phage display interaction mapping

   PMID:28414460

   Open questions at the time

   • Functional consequence of SEPHS1's presence in the complex was not determined
   • Whether SEPHS1 regulates SEPHS2 enzymatic activity within the complex was untested
   • Stoichiometry and dynamics of the complex in vivo were not resolved
5. 2019 Medium

   SEPHS1 was linked to stem cell biology when its knockdown reduced reprogramming efficiency and survival of human ESCs through altered ROS and apoptosis gene expression, establishing a requirement for SEPHS1 in maintaining redox balance during pluripotency acquisition.

   Evidence siRNA knockdown in hESCs with reprogramming efficiency, clonogenicity, and transcriptome readouts

   PMID:31607477

   Open questions at the time

   • Whether SEPHS1's role in reprogramming is direct or secondary to ROS accumulation was unclear
   • Rescue by antioxidant supplementation was not tested
6. 2021 High

   The molecular mechanism of ROS accumulation upon SEPHS1 loss was resolved: SEPHS1 deficiency induces xanthine oxidase and NADPH oxidase while decreasing SOD1/SOD3, causing superoxide and lipid peroxide accumulation and nitric oxide depletion, with downstream consequences including DNA damage, G2/M arrest, and impaired angiogenesis.

   Evidence CRISPR knockout in mouse endothelial cells with measurement of superoxide, lipid peroxide, NO, γH2AX, cell cycle, and tube formation

   PMID:34769076

   Open questions at the time

   • How SEPHS1 regulates xanthine oxidase and NADPH oxidase expression or activity is unknown
   • Whether ATPase activity of SEPHS1 is required for redox regulation was not tested
7. 2021 High

   In vivo knockout established that SEPHS1 is essential for mouse embryonic development: Sephs1-null embryos die by E11.5 with progressive dysregulation of retinoic acid, Wnt, and other signaling pathways preceding DNA damage and apoptosis during gastrulation, demonstrating that redox control by SEPHS1 is upstream of multiple developmental signaling cascades.

   Evidence Systemic Sephs1 KO mice; transcriptomic time-course at E6.5–E8.5; histology and γH2AX/apoptosis markers at E9.5

   PMID:34769078

   Open questions at the time

   • Which tissue(s) are primarily responsible for lethality was not determined by conditional KO
   • Whether antioxidant supplementation can rescue developmental lethality was not tested
8. 2021 Medium

   SEPHS1 was placed upstream of TGF-β/SMAD signaling and EMT: its knockdown decreases SMAD2/3/4 levels and mesenchymal markers in hepatocellular carcinoma cells, and SMAD3 epistasis confirms SEPHS1 acts through this pathway to promote invasion, extending its signaling role beyond development.

   Evidence siRNA knockdown and overexpression in HCC cell lines; Western blot for SMAD2/3/4 and EMT markers; transwell assay; SMAD3 epistasis

   PMID:33622411

   Open questions at the time

   • Whether SEPHS1's effect on SMAD levels is transcriptional or post-translational was not resolved
   • Whether this is mediated through ROS or a parallel mechanism was not established
9. 2021 Medium

   SEPHS1 KO in mouse ESCs demonstrated it is dispensable for pluripotency maintenance but indispensable for cardiac differentiation and tri-lineage germ layer commitment, refining the understanding that SEPHS1's critical role is in differentiation rather than self-renewal.

   Evidence CRISPR KO in mouse ESCs; embryoid body beating assay; RNA-seq; germ layer and gastruloid assays

   PMID:34974300

   Open questions at the time

   • Which specific differentiation signals require SEPHS1 was not identified
   • Whether redox imbalance is the sole cause of differentiation failure was not tested
10. 2022 Medium

    Structural and enzymatic characterization confirmed that SEPHS1 retains ATPase activity but cannot synthesize selenophosphate due to the absence of Sec/Cys at its catalytic position, resolving the long-standing question of whether SEPHS1 is a catalytically dead paralog or has a modified enzymatic function.

    Evidence SEPHS1 homodimer structural modeling; ATPase activity assay; phylogenetic analysis of SEPHS paralogs

    PMID:36202216

    Open questions at the time

    • The biological substrate or product of SEPHS1's ATPase activity is unknown
    • Whether ATPase activity is required for SEPHS1's redox regulatory function has not been tested by catalytic-dead mutants
11. 2022 Medium

    SPS1 deficiency in Drosophila was shown to activate innate immune signaling through both IMD and Toll pathways, broadening SEPHS1's functional repertoire beyond redox regulation to immune defense.

    Evidence RNAi knockdown and double-knockdown epistasis in Drosophila S2 cells; RT-qPCR for antimicrobial peptides

    PMID:35723425

    Open questions at the time

    • Whether immune activation is a direct function of SPS1 or secondary to ROS accumulation was not distinguished
    • Relevance to mammalian innate immunity was not examined
12. 2023 Medium

    SEPHS1 was positioned upstream of Hippo-Yap/Taz signaling in oxidative stress-driven cellular senescence, with its overexpression or Hippo pathway inhibition alleviating intervertebral disc degeneration in vivo, adding another downstream signaling cascade regulated by SEPHS1-dependent redox control.

    Evidence IL-1β-induced NPC senescence model; Sephs1 overexpression; rat IVDD model; Hippo-Yap/Taz pathway inhibition; selenium-deficient diet

    PMID:38105759

    Open questions at the time

    • Mechanism linking SEPHS1 to Hippo pathway regulation is unknown
    • Whether Hippo pathway dysregulation contributes to embryonic lethality in Sephs1 KO mice was not tested
13. 2024 High

    Human genetic evidence established that heterozygous missense variants in SEPHS1 cause a neurodevelopmental disorder, linking its redox-regulatory function to brain development and providing the first Mendelian disease association.

    Evidence Cohort of 9 individuals from 8 families with exon 9 variants; thermal stability assays; ROS and proliferation assays in SH-SY5Y neuronal cells

    PMID:38531365

    Open questions at the time

    • Whether variants act as loss-of-function, gain-of-function, or dominant-negative is not fully resolved
    • Animal models recapitulating the neurodevelopmental phenotype have not been generated
    • The specific neuronal cell types and developmental windows affected are unknown

• The direct molecular mechanism by which SEPHS1's ATPase activity controls ROS-generating and ROS-scavenging enzymes remains unknown, as does the identity of any physiological substrate beyond ATP.
• No substrate or product of SEPHS1 ATPase beyond ADP/Pi has been identified
• Catalytic-dead mutant analysis to separate ATPase from scaffolding functions has not been performed
• Tissue-specific conditional knockouts to define critical cell types for developmental lethality are lacking